These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. α-Synuclein and Lewy pathology in Parkinson's disease. Kalia LV; Kalia SK Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807 [TBL] [Abstract][Full Text] [Related]
6. Controversies over the staging of alpha-synuclein pathology in Parkinson's disease. Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RK Acta Neuropathol; 2008 Jul; 116(1):125-8; author reply 129-31. PubMed ID: 18446352 [No Abstract] [Full Text] [Related]
7. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? Pozo Devoto VM; Falzone TL Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016 [TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease. He Y; Yu Z; Chen S ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251 [TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
10. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Bobela W; Aebischer P; Schneider BL Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339 [TBL] [Abstract][Full Text] [Related]